| Helen M Wu, MD | |
|
607 N Central Ave, Suite 204, Glendale, CA 91203-1804 | |
| (818) 956-1010 | |
| (818) 543-6083 |
| Full Name | Helen M Wu |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 32 Years |
| Location | 607 N Central Ave, Glendale, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326054370 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 036093620 (Illinois) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Glendale Eye Medical Group Inc | 1153235775 | 8 |
News Archive
Sunday church service in Amish country is more than just belting out hymns, reading Bible passages and returning home an hour later to catch a football game or nap.
Hospitals that provide the most rapid emergency angioplasty have specific strategies to expedite the care of patients with heart attacks, researchers at Yale School of Medicine report in the November 13 New England Journal of Medicine.
Seaside Therapeutics LLC today announced that the Company has initiated a Phase 1 clinical trial of STX107, a highly potent, selective mGluR5 antagonist, in development for the treatment of Fragile X Syndrome. The single ascending dose study is designed to evaluate the safety, tolerability and pharmacokinetics of STX107 in healthy volunteers. Fragile X Syndrome is the most common inherited form of mental impairment and the most common known cause of autism.
Researchers from the Centenary Institute have discovered a potential new therapy for cerebral cavernous malformations, a devastating disease that often affects young people and can result in stroke and seizures.
› Verified 2 days ago
| Entity Name | Glendale Eye Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750580940 PECOS PAC ID: 1153235775 Enrollment ID: O20031118000475 |
News Archive
Sunday church service in Amish country is more than just belting out hymns, reading Bible passages and returning home an hour later to catch a football game or nap.
Hospitals that provide the most rapid emergency angioplasty have specific strategies to expedite the care of patients with heart attacks, researchers at Yale School of Medicine report in the November 13 New England Journal of Medicine.
Seaside Therapeutics LLC today announced that the Company has initiated a Phase 1 clinical trial of STX107, a highly potent, selective mGluR5 antagonist, in development for the treatment of Fragile X Syndrome. The single ascending dose study is designed to evaluate the safety, tolerability and pharmacokinetics of STX107 in healthy volunteers. Fragile X Syndrome is the most common inherited form of mental impairment and the most common known cause of autism.
Researchers from the Centenary Institute have discovered a potential new therapy for cerebral cavernous malformations, a devastating disease that often affects young people and can result in stroke and seizures.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Helen M Wu, MD 607 N Central Ave, Suite 204, Glendale, CA 91203-1804 Ph: (818) 956-1010 | Helen M Wu, MD 607 N Central Ave, Suite 204, Glendale, CA 91203-1804 Ph: (818) 956-1010 |
News Archive
Sunday church service in Amish country is more than just belting out hymns, reading Bible passages and returning home an hour later to catch a football game or nap.
Hospitals that provide the most rapid emergency angioplasty have specific strategies to expedite the care of patients with heart attacks, researchers at Yale School of Medicine report in the November 13 New England Journal of Medicine.
Seaside Therapeutics LLC today announced that the Company has initiated a Phase 1 clinical trial of STX107, a highly potent, selective mGluR5 antagonist, in development for the treatment of Fragile X Syndrome. The single ascending dose study is designed to evaluate the safety, tolerability and pharmacokinetics of STX107 in healthy volunteers. Fragile X Syndrome is the most common inherited form of mental impairment and the most common known cause of autism.
Researchers from the Centenary Institute have discovered a potential new therapy for cerebral cavernous malformations, a devastating disease that often affects young people and can result in stroke and seizures.
› Verified 2 days ago
Dr. Vinh Tan Tran, MD, PHD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1808 Verdugo Blvd, Suite 206, Glendale, CA 91208 Phone: 818-790-7611 Fax: 818-952-5634 | |
Elsa Aghaian, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 607 N. Central Ave., Suite 204, Glendale, CA 91203 Phone: 818-956-1010 Fax: 818-543-6083 | |
Katherine Chen, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 409 N Central Ave, Glendale, CA 91203 Phone: 818-265-7777 | |
Haroutun Harry Hovanesian, M.D. Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 409 N Central Ave, Glendale, CA 91203 Phone: 818-265-7777 Fax: 818-241-0087 | |
Dr. Richard A Weise, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 607 N Central Ave, Suite 105, Glendale, CA 91203 Phone: 818-956-1010 Fax: 818-543-6083 | |
Dr. Kay Loren Park, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 222 W Eulalia St, Ste 110, Glendale, CA 91204 Phone: 818-551-7127 Fax: 818-551-7131 | |
Jerold Edmond Beeve, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 1809 Verdugo Blvd, Suite 150, Glendale, CA 91208 Phone: 818-790-8001 Fax: 818-790-7757 |